Summary: Today, we revisit a small developmental firm called Zynerba Pharmaceuticals. The company is advancing
Summary: Affimed reported mixed Q2 earnings that revealed more milestone payments from their partnerships. In
Summary: Cyngn has filed proposed terms for a $30 million IPO. The firm is developing
Summary: I’ve compared 360 DigiTech’s financials with its four most important peers. Based on the
Summary: Cyngn has filed to raise $35 million in an IPO from the sale of
Summary: XELA offers exactly what most people are talking about these days: digital transformation. The
Summary: Advanced Human Imaging has filed to raise $24 million in a U.S. IPO. The
Summary: Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company that is developing compounds that activate Tie2
Summary: Absci, a synthetic biology company whose platform technology aids in the drug discovery process,
Summary: AbSci has filed to raise $200 million in a U.S. IPO. The firm is
